Skip to main content

Greenland Mines Ltd

GRML
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001907223

In the last 90 days, Greenland Mines Ltd insiders filed 3 open-market purchases and 0 sales; 48 institutions reported holding it in 13F filings for Q2 2026, worth $4.97M in total; no superinvestor holds it.

Other share classesGRMLW

Holders of 5% or more of GRML

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Greenland Mines Ltd, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Greenland Mines Ltd on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

2 Schedule 13D and 13G filings on Greenland Mines Ltd, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on GRML
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jul 2, 20253:42 PM ETAustria Capital LLC13G/A4.99%1.62M shares−4.41 ppfrom 9.40%Below 5%May 14, 2025SEC
Jul 2, 20253:40 PM ETAustria Capital LLC13G9.40%2.00M sharesNewDec 4, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Greenland Mines Ltd shares.

No Form 144 notices for Greenland Mines Ltd are on file.